TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3330526

Group type: EXPERIMENTAL
Intervention: AQ‐A 39 (falipamil), 2 mg kg‐1
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol, 0.1 mg kg‐1
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: AQ‐A 39 (falipamil)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 10
Study: 31164277

Group type: EXPERIMENTAL
Intervention: Weekly cisplatin
Number of subjects: 98

Group type: COMPARATOR
Intervention: 3-weekly cisplatin
Number of subjects: 98
Study: 31364232

Group type: EXPERIMENTAL
Intervention: Teduglutide
Number of subjects: 10

Group type: COMPARATOR
Intervention: L-NMMA + Teduglutide
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal saline + Teduglutide
Number of subjects: 10

Group type: COMPARATOR
Intervention: L-NMMA + Placebo
Number of subjects: 10
Study: 31556273

Group type: EXPERIMENTAL
Intervention: Hetero-Rituximab (test)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Rituximab (Roche, reference)
Number of subjects: 40
Study: 25769495

Group type: EXPERIMENTAL
Intervention: Tumour necrosis factor inhibitor strategy
Number of subjects: 432

Group type: COMPARATOR
Intervention: Combined disease modifying drug strategy
Number of subjects: 432
Study: 23394263

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy (ertapenem 1 g per day for 3 days, followed by oral levofloxacin 500 mg per day and metronidazole 1.5 g per day for 7 days)
Number of subjects: 610

Group type: COMPARATOR
Intervention: Emergency appendectomy
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy
Number of subjects: 610
Study: 21936253

Group type: EXPERIMENTAL
Intervention: Unreamed intramedullary nailing
Number of subjects: 50

Group type: COMPARATOR
Intervention: AO tubular external fixation
Number of subjects: 50
Study: 20047114

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 42
Study: 17154642

Group type: EXPERIMENTAL
Intervention: Methotrexate therapy (starting dose of 10-15 mg/m2/week orally, increased to 15-20 mg/m2/week parenterally)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy with methotrexate and an NSAID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (1 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily folate supplementation
Number of subjects: 0
Study: 15701229

Group type: EXPERIMENTAL
Intervention: Subjects with VM lesions
Number of subjects: 15

Group type: COMPARATOR
Intervention: Brain-damaged comparison subjects
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal individuals
Number of subjects: 15
Study: 12580112

Group type: EXPERIMENTAL
Intervention: Effervescent tablet of potassium chloride (2 g)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Common tablet of potassium chloride (2 g)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No drug treatment
Number of subjects: 18
Study: 9240183

Group type: EXPERIMENTAL
Intervention: 20 mL of 2% lignocaine gel for 25 min
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 20 mL of 2% lignocaine gel for 15 min
Number of subjects: 150

Group type: COMPARATOR
Intervention: Plain lubricating gel for 5 min
Number of subjects: 150

Group type: COMPARATOR
Intervention: Plain lubricating gel for 25 min
Number of subjects: 150

Group type: COMPARATOR
Intervention: 20 mL of 2% lignocaine gel for 5 min
Number of subjects: 150
Study: 8252507

Group type: EXPERIMENTAL
Intervention: Total androgen blockade (orchiectomy + nilutamide)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Orchiectomy alone (placebo)
Number of subjects: 457
Study: 3684395

Group type: EXPERIMENTAL
Intervention: Research breast-feeding bedside counseling by a trained counselor with eight telephone calls during the first 3 months
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Research discharge pack
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Research counseling with research discharge pack
Number of subjects: 343

Group type: COMPARATOR
Intervention: Routine breast-feeding counseling provided in the hospital by nurses
Number of subjects: 343

Group type: COMPARATOR
Intervention: Commercial discharge pack
Number of subjects: 343
Study: 31987331

Group type: EXPERIMENTAL
Intervention: Supplemental CoQ10 (300 mg/kg)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Supplemental CoQ10 (600 mg/kg)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Supplemental CoQ10 (900 mg/kg)
Number of subjects: 128

Group type: COMPARATOR
Intervention: No CoQ10 supplementation
Number of subjects: 128
Study: 29970155

Group type: EXPERIMENTAL
Intervention: Acupoint herbal plaster (AHP) using Shaofuzhuyu decoction on acupoints Shenque (CV8), Guanyuan (CV4), Qihai (CV5), Ciliao (BL32), and Zigong (EX-CA1)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Acupoint placebo plaster (APP) on the same acupoints
Number of subjects: 180

Group type: COMPARATOR
Intervention: Waiting-list control group (WL) with no intervention
Number of subjects: 180
Study: 28784280

Group type: EXPERIMENTAL
Intervention: PnCj-PPS group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo-PPS group
Number of subjects: 42
Study: 26158926

Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (Catalys; Abbott Medical Optics)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional phacoemulsification
Number of subjects: 29
Study: 24050486

Group type: EXPERIMENTAL
Intervention: Promotion text message group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Prevention text message group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Attention-control text message group
Number of subjects: 120
Study: 21967909

Group type: EXPERIMENTAL
Intervention: Warmed, unfolded cotton sheet and cotton blanket
Number of subjects: 578

Group type: COMPARATOR
Intervention: Two folded, warmed cotton blankets
Number of subjects: 578
Study: 17911541

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 0
Study: 15377061

Group type: EXPERIMENTAL
Intervention: Combination dietary supplement
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 11474254

Group type: COMPARATOR
Intervention: CMF (cyclophosphamide, methotrexate, 5-fluorouracil)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil)
Number of subjects: 145
Study: 9734807

Group type: EXPERIMENTAL
Intervention: Automated refractor (Hoya AR-570)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Subjective refraction by clinicians
Number of subjects: 86

Group type: COMPARATOR
Intervention: Automated refractor
Number of subjects: 86
Study: 8046120

Group type: COMPARATOR
Intervention: Nifedipine (10 mg capsules)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Nitrendipine (5 mg from vial)
Number of subjects: 161
Study: 2929467

Group type: EXPERIMENTAL
Intervention: Rate-responsive pacing
Number of subjects: 10

Group type: COMPARATOR
Intervention: VVI pacing
Number of subjects: 10
Study: 29483185

Group type: EXPERIMENTAL
Intervention: IDegLira
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basal-Bolus Insulin
Number of subjects: 0
Study: 26969308

Group type: EXPERIMENTAL
Intervention: Telephone genetic counseling (TC)
Number of subjects: 479

Group type: COMPARATOR
Intervention: Usual care (UC; in-person) genetic counseling
Number of subjects: 479
Study: 25096690

Group type: COMPARATOR
Intervention: No brief intervention
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: Brief Negotiated Interview (BNI)
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MOTIV)
Number of subjects: 528
Study: 22739369

Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplements (5 g/d, 2 g EPA, 1 g DHA)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Corn/soy oil (PL) (5 g/d)
Number of subjects: 116
Study: 20604814

Group type: EXPERIMENTAL
Intervention: Induction therapy with 80 mg Tokyo strain BCG instillation once weekly for eight consecutive weeks.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Maintenance therapy with four additional BCG instillations after achieving CR.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Observation group (control) after induction therapy.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Induction therapy with BCG.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Maintenance therapy with BCG.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Induction and maintenance therapy with BCG.
Number of subjects: 90
Study: 17428617

Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy (MET)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Education control
Number of subjects: 81
Study: 16554456

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/d) for 18 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg/d) coadministered in the last 4 study days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Paroxetine and Aspirin combination
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 20
Study: 12765282

Group type: EXPERIMENTAL
Intervention: Contour-based segmentation algorithm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Edge detector
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Algorithm evaluation
Number of subjects: 0
Study: 10670114

Group type: EXPERIMENTAL
Intervention: rocuronium 0.05 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: vecuronium 0.007 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: saline (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 9078354

Group type: EXPERIMENTAL
Intervention: IVIg (500 mg/kg/month)
Number of subjects: 250
Study: 1856146

Group type: EXPERIMENTAL
Intervention: Netilmicin once daily (6.6 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amikacin once daily (14.5 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Netilmicin thrice daily (tid)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Netilmicin twice daily (bd)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amikacin twice daily (bd)
Number of subjects: 60

Group type: COMPARATOR
Intervention: All regimens (including lower frequencies)
Number of subjects: 60
Study: 6611665

Group type: EXPERIMENTAL
Intervention: Quadriceps femoris muscle setting
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Straight leg raise
Number of subjects: 40
Study: 30999989

Group type: EXPERIMENTAL
Intervention: CABG in EXCEL trial
Number of subjects: 909

Group type: COMPARATOR
Intervention: CABG in SYNTAX trial
Number of subjects: 909
Study: 30650281

Group type: EXPERIMENTAL
Intervention: Problem-based learning (PBL)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Lecture-based learning (LBL)
Number of subjects: 162
Study: 25904781

Group type: EXPERIMENTAL
Intervention: Adaptive working memory training
Number of subjects: 0
Study: 24698485

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg once daily
Number of subjects: 484

Group type: COMPARATOR
Intervention: Darunavir 800 mg plus ritonavir 100 mg once daily
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 484

Group type: COMPARATOR
Intervention: Darunavir plus ritonavir
Number of subjects: 484
Study: 23000845

Group type: EXPERIMENTAL
Intervention: Psychological treatment
Number of subjects: 64
Study: 19317821

Group type: EXPERIMENTAL
Intervention: Inhaled insulin (AERx iDMS)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Subcutaneous insulin (s.c.)
Number of subjects: 304
Study: 17613977

Group type: EXPERIMENTAL
Intervention: 18 session intervention
Number of subjects: 171

Group type: COMPARATOR
Intervention: Delayed-intervention condition
Number of subjects: 171
Study: 15258698

Group type: EXPERIMENTAL
Intervention: Oral cisplatin (10‐30 mg/m2)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intravenous cisplatin (30‐min infusions)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Oral cisplatin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Unbound platinum
Number of subjects: 32
Study: 11739089

Group type: EXPERIMENTAL
Intervention: Moderate-fat recovery diet (35% of energy, MFAT)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Very low-fat recovery diet (10% of energy, LFAT)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Endurance run (2-h treadmill run at 67% of VO2 max)
Number of subjects: 7
Study: 10561263

Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionated radiation therapy (ACC HFX RT) with 54 Gy in 36 fractions over 18 treatment days plus concurrent daily carboplatin/etoposide (CE) (group 1, n = 55)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Cisplatin/etoposide (PE) chemotherapy alone (group 2, n = 54)
Number of subjects: 210
Study: 10150495

Group type: EXPERIMENTAL
Intervention: Salbutamol (200 micrograms) with HFA134a
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 micrograms, 100 micrograms) with HFA134a
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salbutamol (HFA134a) used as required
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salmeterol (50 micrograms) twice daily with HFA134a
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) (250 micrograms) twice daily with HFA134a
Number of subjects: 0
Study: 2285609

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) 30 mg/day + Bromocriptine (B) 5 mg/day
Number of subjects: 171

Group type: COMPARATOR
Intervention: Tamoxifen (TAM) 30 mg/day + Placebo
Number of subjects: 171
Study: 7029648

Group type: EXPERIMENTAL
Intervention: PGE2 0.04 mg four times daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PGE2 0.25 mg four times daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PGE2 0.5 mg four times daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: ASA (650 mg four times daily)
Number of subjects: 32
Study: 30280324

Group type: EXPERIMENTAL
Intervention: Bleaching tray (White Class, FGM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Whitening strips (White Strips, Oral-b)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Prefilled disposable trays (Opalescence Go, Ultradent)
Number of subjects: 60
Study: 27891632

Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg for 8 weeks (GU study)
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg for 6 weeks (DU study)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg for 8 weeks (GU study)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg for 6 weeks (DU study)
Number of subjects: 456
Study: 25010152

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham taping
Number of subjects: 26
Study: 24094310

Group type: EXPERIMENTAL
Intervention: Central hole myopic contact lens
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-hole contact lens
Number of subjects: 10
Study: 21936957

Group type: EXPERIMENTAL
Intervention: Skill-building intervention
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Price reductions on fruits, vegetables, low-joule soft drinks, and water
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Combination of skill-building and price reductions
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 500
Study: 18347178

Group type: EXPERIMENTAL
Intervention: Tamoxifen-based therapy (ABCSG Trial 05)
Number of subjects: 1201

Group type: EXPERIMENTAL
Intervention: Tamoxifen-based therapy (ABCSG Trial 06)
Number of subjects: 1201
Study: 16686873

Group type: EXPERIMENTAL
Intervention: Patient report of change in depressive symptoms using Clinical Global Impressions of Change (CGI-C)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Patient report of at least 'much improved'
Number of subjects: 56
Study: 14552520

Group type: EXPERIMENTAL
Intervention: Nurse advice service
Number of subjects: 1182

Group type: COMPARATOR
Intervention: On-call pediatricians
Number of subjects: 1182
Study: 10761165

Group type: EXPERIMENTAL
Intervention: OROS (methylphenidate HCl) 18 mg qd
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) methylphenidate 20 mg qd
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate-release (IR) formulation (three 5 mg doses every 4 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: OROS (methylphenidate HCl)
Number of subjects: 0
Study: 8598756

Group type: EXPERIMENTAL
Intervention: Transdermal 17 beta‐oestradiol 200 micrograms daily for 3 months, then 3 months with added cyclical dydrogesterone 10mg daily for 12 days each month
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo patches and tablets according to the same regimen
Number of subjects: 61
Study: 1428436

Group type: EXPERIMENTAL
Intervention: Minoxidil 2%
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 3903070

Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (1000 mg bolus and 1000 mg daily for 10 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard dose methylprednisolone (100 mg bolus and 100 mg daily for 10 days)
Number of subjects: 0
Study: 29938626

Group type: EXPERIMENTAL
Intervention: Anxious-mood induction
Number of subjects: 22

Group type: COMPARATOR
Intervention: Neutral-mood induction
Number of subjects: 22
Study: 29297950

Group type: EXPERIMENTAL
Intervention: 400 mg vaginal progesterone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 26945226

Group type: EXPERIMENTAL
Intervention: Active peripheral nerve stimulation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham peripheral nerve stimulation
Number of subjects: 19
Study: 23911112

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (LCD; n=22)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Low-fat diet + orlistat (LFD + O; n=24)
Number of subjects: 46
Study: 23146983

Group type: EXPERIMENTAL
Intervention: Citalopram, 20 mg/d for 3 months
Number of subjects: 44

Group type: COMPARATOR
Intervention: Psychological training (6 sessions of 1-hour each)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison between Citalopram and Psychological training
Number of subjects: 44
Study: 19918017

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: COMPARATOR
Intervention: Caffeine
Number of subjects: 11
Study: 18819472

Group type: EXPERIMENTAL
Intervention: Oral tacrolimus
Number of subjects: 58

Group type: COMPARATOR
Intervention: Model building group (n=41)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Validation group (n=17)
Number of subjects: 58
Study: 17092654

Group type: EXPERIMENTAL
Intervention: Psychological assessments before and after biopsy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Natural killer (NK) cell activity and INF gamma production
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokine production (IL‐4, IL‐6, IL‐10)
Number of subjects: 0
Study: 15497661

Group type: EXPERIMENTAL
Intervention: Test formulation (Osalen 10 mg tablets)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Reference formulation (originator product)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Test and Reference formulations
Number of subjects: 89
Study: 11273926

Group type: EXPERIMENTAL
Intervention: Fast-Track group (bypassed PACU, directly admitted to SSRU)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (admitted to PACU then SSRU)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Fast-Track group
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 155
Study: 9290451

Group type: EXPERIMENTAL
Intervention: Coculture with buffalo rat liver cells
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control group (no coculture)
Number of subjects: 203
Study: 8318320

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% infused at 5 ml h‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bupivacaine infusion
Number of subjects: 20
Study: 3711963

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 68
Study: 31851082

Group type: EXPERIMENTAL
Intervention: Fragility Index (FI)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Fragility Quotient (FQ)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: P-value
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Patients lost to follow up
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Correlation between FI and P-value
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Correlation between FI and sample size
Number of subjects: 32
Study: 31051087

Group type: EXPERIMENTAL
Intervention: 8 mmol sodium nitrate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 16 mmol sodium nitrate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 24 mmol sodium nitrate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 10
Study: 29533264

Group type: COMPARATOR
Intervention: Major Adverse Cardiac Events (MACEs)
Number of subjects: 6992

Group type: COMPARATOR
Intervention: Major Adverse Postoperative Events (MAPEs) without troponin elevation
Number of subjects: 6992

Group type: COMPARATOR
Intervention: Major Adverse Postoperative Events (MAPEs) with troponin elevation but without MI
Number of subjects: 6992

Group type: COMPARATOR
Intervention: Troponin elevation (all types)
Number of subjects: 6992
Study: 26493601

Group type: EXPERIMENTAL
Intervention: Family-based cognitive-behavioral therapy for chronic pain
Number of subjects: 330
Study: 24898857

Group type: COMPARATOR
Intervention: BufferGel
Number of subjects: 3099

Group type: COMPARATOR
Intervention: PRO 2000
Number of subjects: 3099
Study: 22238412

Group type: EXPERIMENTAL
Intervention: rTMS(R) before PT
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: rTMS(R) after PT
Number of subjects: 30

Group type: COMPARATOR
Intervention: rTMS(S)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (Sham rTMS)
Number of subjects: 30